The largest database of trusted experimental protocols

Sabouraud dextrose agar sda

Manufactured by Lab M
Sourced in United Kingdom

Sabouraud Dextrose Agar (SDA) is a culture medium used for the isolation and cultivation of fungi. It is formulated with dextrose as the primary carbohydrate source and peptones as the nitrogen source, providing optimal growth conditions for a wide range of fungal species.

Automatically generated - may contain errors

2 protocols using sabouraud dextrose agar sda

1

Culturing Oral Microbiome Organisms

Check if the same lab product or an alternative is used in the 5 most similar protocols
Microorganisms used in the study were cultured and maintained under the following conditions.
Candida albicans ATCC 90028 was maintained on Sabouraud Dextrose Agar (SDA; LabM, Lancashire, UK), and cultured in yeast nitrogen base (YNB; BD Difco, Oxford, UK) supplemented with 100 mmol L−1 glucose (Fisher Scientific, Loughborough, UK) overnight under aerobic conditions and at 37°C. The oral bacterial species used were S. sanguinis NCTC 7863, S. gordonii ATCC 10558, A. viscosus ATCC 1598, A. odontolyticus NCTC 9935 and P. gingivalis NCTC 11834. Streptococci were cultured aerobically on blood agar (BA; Blood Agar Base, LabM, Heywood, UK) supplemented with 5% (v/v) defibrinated horse blood (TCS Biosciences, Buckingham, UK) at 37°C. For liquid culture, streptococci were cultured in Brain Heart Infusion (BHI) broth (LabM) under aerobic conditions at 37°C. Actinomyces species and P. gingivalis were maintained on fastidious anaerobe agar (LabM) supplemented with 5% (v/v) defibrinated horse blood (TCS Biosciences), and for liquid culture, were cultured in BHI supplemented with 50 μg hemin per ml (Sigma, Gillingham, UK) and 10 μg vitamin K per ml, under anaerobic conditions at 37°C.
+ Open protocol
+ Expand
2

Antifungal Compound Efficacy Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Institute of Public Health (WIV, Brussels, Belgium) and Prof. J. Maertens (University Hospital Leuven, Belgium) and included A. flavus (B59000), A. niger (J930117), A. terreus (IHEM 5918) and A. fumigatus (B19119 and AF198-R [azole-resistant]). The isolates were cultivated on Sabouraud dextrose agar (SDA) (Lab M, U.K.) supplemented with 0.5% (w/v) chloramphenicol (Sigma-Aldrich, Diegem, Belgium). Stocks with a concentration of 5x10 6 colony forming units (cfu)/ml were prepared in RPMI-MOPS with 10% glycerol and 0.01% Tween-80 and frozen in liquid nitrogen. For the in vitro experiments, pre-titrated cryopreserved vials were used. Fresh inocula of A. fumigatus B19119 were used for the in vivo studies.
Antifungal compounds MIL, VOR (Sigma-Aldrich) and POS (Merck, Noxafil® oral formulation 40 mg/ml) were used as reference drugs. Dafra Pharma Research and Development (Turnhout, Belgium) supplied liposomal OlPC (18 mg/ml or 41.5 µM) for in vitro and in vivo use.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!